Innovative microfluidic chip uses only standard lab microscope to spot nano-biomolecules without any fluorescent labels
A novel invention by a team of researchers from the National University of Singapore (NUS) holds promise for a faster and cheaper way to diagnose diseases with high accuracy. Professor Zhang Yong from the Department of Biomedical Engineering at the NUS Faculty of Engineering and his team have developed a tiny microfluidic chip that could effectively detect minute amounts of biomolecules without the need for complex lab equipment.
Diseases diagnostics involves detection and quantification of nano-sized bio-particles such as DNA, proteins, viruses, and exosomes (extracellular vesicles). Typically, detection of biomolecules such as proteins are performed using colorimetric assays or fluorescent labelling with a secondary antibody for detection, and requires complex optical detection equipment such as fluorescent microscopy or spectrophotometry.
One alternative to reduce cost and complexity of disease detection is the adoption of label-free techniques, which are gaining traction in recent times. However, this approach requires precision engineering of nano-features (in a detection chip), complex optical setups, novel nano-probes (such as graphene oxide, carbon nanotubes, and gold nanorods) or additional amplification steps such as aggregation of nanoparticles to achieve sensitive detection of biomarkers.
“Our invention is an example of disruptive diagnostics. This tiny biochip can sensitively detect proteins and nano-sized polymer vesicles with a concentration as low as 10ng/mL (150 pM) and 3.75?g/mL respectively. It also has a very small footprint, weighing only 500 mg and is 6mm³ in size. Detection can be performed using standard laboratory microscopes, making this approach highly attractive for use in point-of-care diagnostics,” explained Prof Zhang.
His team, comprising Dr Kerwin Kwek Zeming and two NUS PhD students Mr Thoriq Salafi and Ms Swati Shikha, published their findings in scientific journal Nature Communications on 28 March 2018.
Novel approach for disease diagnosis
This novel fluorescent label-free approach uses the lateral shifts in the position of the microbead substrate in pillar arrays, for quantifying the biomolecules, based on the change in surface forces and size, without the need of any external equipment. Due to the usage of lateral displacement, the nano-biomolecules can be detected in real-time and the detection is significantly faster in comparison to fluorescent label based detection.
“These techniques can also be extended to many other types of nano-biomolecules, including nucleic acid and virus detection. To complement this chip technology, we are also developing a portable smartphone-based accessory and microfluidic pump to make the whole detection platform portable for outside laboratory disease diagnostics. We hope to further develop this technology for commercialisation,” said Prof Zhang.
The Latest on: Disease detection
via Google News
The Latest on: Disease detection
What's the First Line of Defense in Early Detection of Head and Neck Cancer? SCREENINGS
on April 19, 2019 at 6:07 pm
"Head and neck cancer used to be a disease of people in their 60s and 70s, typically found in people who use an excessive amount of tobacco and alcohol. That has shifted significantly to those in ... […]
Volatile Biomarkers Could Lead to Early Detection of Parkinson Disease
on April 19, 2019 at 10:22 am
Biomarkers of Parkinson Disease, detected by smell and analysis of sebum, could lead to a noninvasive diagnostic test for the disease. Volatile biomarkers of Parkinson disease (PD) could be identified ... […]
U of M researcher hopes to develop first early detection test for ovarian cancer
on April 18, 2019 at 10:05 pm
Skubitz found five new biomarkers, linked to the disease. When found at elevated levels in a woman's blood, it signals the presence of ovarian cancer. "We look at the levels of these five markers in ... […]
A possible blood test for early-stage Alzheimer's disease
on April 18, 2019 at 5:52 am
Alzheimer's disease is, of course ... It is not curable and those afflicted eventually die. Plasma amyloid-β detection by comparing levels of Aβ by self-standard (CLASS) method on interdigitated ... […]
PathAI raises $60 million for its computer vision-based pathogen detection technology
on April 17, 2019 at 6:36 pm
With a clinical version of PathAI‘s computer vision-based pathogen detection service still at ... cancerous cells or other disease-causing agents. These days, PathAI’s technology is used ... […]
Swine Cough Monitoring Technology Offers Early Detection and Treatment
on April 17, 2019 at 1:15 pm
Can technology outpace a livestock caregiver’s watchful eye? Clinical disease detection is typically the direct responsibility of site managers and is a function of skill, experience and time spent on ... […]
New automated biological-sample analysis systems to accelerate disease detection
on April 17, 2019 at 12:36 pm
Microfluidics refers to the manipulation of fluids in microscale devices. Commonly called "labs on a chip," microfluidic systems are used to study and analyze very small-scale chemical or biological ... […]
Direct detection of bacteremia by exploiting host-pathogen interactions of lipoteichoic acid and lipopolysaccharide
on April 17, 2019 at 8:07 am
The early diagnosis of bacteremia and initiation of treatment saves lives, especially in high-disease burden areas ... developed and clinically validated a novel method for the direct detection of ... […]
Powerful ultra-high-field MRIs for early disease detection
on April 16, 2019 at 5:45 am
The widespread adoption of magnetic resonance imaging (MRI) revolutionized clinical medicine, and the revolution has not stopped. Scientists in an EU-funded project are exploring ways to make MRIs ... […]
via Bing News